Skip To Main Content
Oliver Hamer on Muck Rack

Oliver Hamer

As seen in: Folha de S.Paulo, UOL, Terra, Yahoo Canada, Yahoo News UK, BMJ Open, The Conversation, Medical Xpress, Scroll.in, Philadelphia Tribune and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Oliver

Contact Oliver, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Weight‑loss shots may create a new kind of yo‑yo dieting

|
By Oliver Hamer
| Philadelphia Tribune Verified
For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after eating, helping people feel fuller and less hungry. Mounjaro, whose active ingredient is tirzepatide, also acts on another hormone involved in appetite and blood sugar control.
Open in Who Shared Issue with article?

Weight-loss injections could set off new kind of ‘yo-yo dieting’

|
By Oliver Hamer
| Scroll.in Verified
For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after eating, helping people feel fuller and less hungry. Mounjaro, whose active ingredient is tirzepatide, also acts on another hormone involved in appetite and blood sugar control.
Open in Who Shared Issue with article?

Canetas emagrecedoras podem criar um novo tipo de 'dieta ioiô'

|
By Oliver Hamer
| Folha de S.Paulo Verified
Para muitas pessoas que vivem com obesidade, os medicamentos mais recentes para perda de peso, como Wegovy e Mounjaro, têm sido transformadores. Esses remédios são classificados como agonistas de GLP-1 pois imitam hormônios liberados após as refeições, ajudando a pessoa a se sentir mais saciada e com menos fome. O Mounjaro, cujo princípio ativo é a tirzepatida, também atua sobre outro hormônio envolvido no apetite e no controle da glicemia.
Open in Who Shared Issue with article?
See all 14 licensed articles (15 Total)